New Technology Transfer Date definition

New Technology Transfer Date means, with respect to New Technology necessary to manufacture a particular Selected Thermal Paper Product, the date on which Oji or one of its Subsidiaries provides VCP with a know-how book that describes in reasonably adequate detail such New Technology.

Related to New Technology Transfer Date

  • Technology Transfer Plan will have the meaning set forth in Section 4.1.

  • Technology Transfer Agreement has the meaning given in Section 2.2(a).

  • Technology Transfer has the meaning set forth in Section 5.2.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Initial Development Plan has the meaning set forth in Section 3.2(b).

  • New Technology means any invention, discovery, improvement, or innovation that was not available to the District on the effective date of the contract, whether or not patentable, including, but not limited to, new processes, emerging technology, machines, and improvements to or new applications of existing processes, machines, manufactures and software. Also included are new computer programs, and improvements to, or new applications of, existing computer programs, whether or not copyrightable and any new process, machine, including software, and improvements to, or new applications of, existing processes, machines, manufactures and software.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Initial application means the Application first provided to MFA on or before an Application Deadline to request an allocation of Tax Credits.

  • Transferred Technology has the meaning set forth in Section 2.3(a).

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Commercial Development Plan means the written commercialization plan attached as Appendix E.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.